Skip to main content
SpringerLink
Log in

Duloxetine increases risk of postpartum haemorrhage

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. serotonin-norepinephrine reuptake inhibitor

Reference

  • Huybrechts K, et al. Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study. BMJ 2020: m237, No. 368, 19 Feb 2020. Available from: URL: https://doi.org/10.1136/bmj.m237

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Duloxetine increases risk of postpartum haemorrhage. Reactions Weekly 1793, 10 (2020). https://doi.org/10.1007/s40278-020-75352-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-75352-z

Search

Navigation